DAPK1 is also mediated in anti-cancer drug resistance to 5-fluorouracil in endometrial adenocarcinoma cells [56], anti-epidermal growth factor receptor antibodies in lung cancer cells [57], gemcitabine in pancreatic cancer cells [58], and cisplatin in cervical squamous cancer cells [59]. The gene discussed is DAPK1; the disease is cancer.